Promising Outlook for Revolution Medicines: Buy Rating Backed by Strong RAS ON Inhibitor Progress and Financial Stability
In a report released on November 7, Jonathan Chang from Leerink Partners reiterated a Buy rating on Revolution Medicines (RVMD – Research ...
Revolution Medicines (NASDAQ:RVMD) Given New $68.00 Price Target at Needham & Company LLC
Revolution Medicines (NASDAQ:RVMD – Free Report) had its target price increased by Needham & Company LLC from $61.00 to $68.00 in a report issued on Thursday morning,Benzinga reports. They currently ...
Stifel Nicolaus Reaffirms Their Buy Rating on Revolution Medicines (RVMD)
Stifel Nicolaus analyst Benjamin Burnett maintained a Buy rating on Revolution Medicines (RVMD – Research Report) on November 8 and set a ...
bovnews5d
Needham Issues Buy Rating for Revolution Medicines Inc (RVMD) Stock
On Friday, Revolution Medicines Inc (RVMD) stock saw a modest uptick, ending the day at $60.44 which represents a slight increase of $1.34 or 2.27% from the prior close of $59.1. The stock opened at ...
Yahoo Finance5d
Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insight
Warning! GuruFocus has detected 6 Warning Signs with RVMD. Revolution Medicines Inc (NASDAQ:RVMD), a clinical-stage precision ...
Revolution Medicines, Inc. (NASDAQ:RVMD) Q3 2024 Earnings Call Transcript
Revolution Medicines, Inc. (NASDAQ: RVMD) Q3 2024 Earnings Call Transcript November 6, 2024 Revolution Medicines, Inc. misses on earnings expectations. Reported EPS is $-0.94 EPS, expectations were ...